Further studies on the pathophysiology of testicular feminization syndrome.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000328:Adult; D013734:Androgen-Insensitivity Syndrome / Q000097:blood* / Q000503:physiopathology*; D000731:Androstanes / Q000652:urine; D001798:Blood Proteins; D002247:Carbon Isotopes; D003117:Color Vision Defects; D013196:Dihydrotestosterone / Q000627:therapeutic use; D005058:Eunuchism; D006801:Humans; D007006:Hypogonadism / Q000097:blood* / Q000188:drug therapy; D008607:Intellectual Disability; D008297:Male; D000857:Olfaction Disorders; D011485:Protein Binding; D012729:Sex Chromosome Aberrations; D013261:Sterols / Q000652:urine; D013739:Testosterone / Q000097:blood* / Q000378:metabolism; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D000731:Androstanes; D001798:Blood Proteins; D002247:Carbon Isotopes; D013261:Sterols; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone